F.I. Carroll

420 total citations
17 papers, 358 citations indexed

About

F.I. Carroll is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Organic Chemistry. According to data from OpenAlex, F.I. Carroll has authored 17 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cellular and Molecular Neuroscience, 7 papers in Molecular Biology and 4 papers in Organic Chemistry. Recurrent topics in F.I. Carroll's work include Neurotransmitter Receptor Influence on Behavior (7 papers), Neuroscience and Neuropharmacology Research (4 papers) and Receptor Mechanisms and Signaling (4 papers). F.I. Carroll is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (7 papers), Neuroscience and Neuropharmacology Research (4 papers) and Receptor Mechanisms and Signaling (4 papers). F.I. Carroll collaborates with scholars based in United States and Germany. F.I. Carroll's co-authors include Anita H. Lewin, John W. Boja, S. Wayne Mascarella, Michael J. Kuhar, Karley Y. Little, Barbara Cassin, Philip Abraham, J. Bruce Pitner, Philip Abraham and Pravin L. Kotian and has published in prestigious journals such as Biological Psychiatry, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

F.I. Carroll

17 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F.I. Carroll United States 11 210 183 91 30 27 17 358
F. Ivy Carroll United States 8 272 1.3× 217 1.2× 69 0.8× 20 0.7× 40 1.5× 9 406
Jan R. Flynn United States 12 199 0.9× 191 1.0× 111 1.2× 19 0.6× 33 1.2× 39 458
Nilgün Kula United States 11 208 1.0× 188 1.0× 54 0.6× 14 0.5× 30 1.1× 20 379
Venkatesalu Bakthavachalam United States 14 260 1.2× 307 1.7× 93 1.0× 16 0.5× 21 0.8× 23 420
Philip Abraham United States 12 311 1.5× 315 1.7× 164 1.8× 59 2.0× 41 1.5× 22 643
Willem F. M. Van Bever Belgium 5 120 0.6× 112 0.6× 56 0.6× 32 1.1× 18 0.7× 5 289
G. VON SPRECHER Switzerland 11 185 0.9× 197 1.1× 274 3.0× 31 1.0× 22 0.8× 14 526
H. WIKSTROEM Sweden 14 342 1.6× 377 2.1× 190 2.1× 44 1.5× 25 0.9× 23 604
Ralph A. Lessor United States 14 222 1.1× 293 1.6× 93 1.0× 34 1.1× 7 0.3× 37 534
J. Lépagnol France 12 243 1.2× 284 1.6× 165 1.8× 55 1.8× 11 0.4× 18 508

Countries citing papers authored by F.I. Carroll

Since Specialization
Citations

This map shows the geographic impact of F.I. Carroll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F.I. Carroll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F.I. Carroll more than expected).

Fields of papers citing papers by F.I. Carroll

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F.I. Carroll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F.I. Carroll. The network helps show where F.I. Carroll may publish in the future.

Co-authorship network of co-authors of F.I. Carroll

This figure shows the co-authorship network connecting the top 25 collaborators of F.I. Carroll. A scholar is included among the top collaborators of F.I. Carroll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F.I. Carroll. F.I. Carroll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Thomas, James B., Richard B. Rothman, S. Wayne Mascarella, et al.. (2004). Importance of Phenolic Address Groups in Opioid Kappa Receptor Selective Antagonists. Journal of Medicinal Chemistry. 47(4). 1070–1073. 23 indexed citations
2.
Rothman, Richard B. & F.I. Carroll. (2000). Opportunities for Medication Development in Obesity. Drug Development Research. 51(2). 49–51. 2 indexed citations
3.
Damaj, M. Imad, Jennifer E. Slemmer, F.I. Carroll, & Billy R. Martin. (1999). Pharmacological Characterization of Nicotine’s Interaction with Cocaine and Cocaine Analogs. Journal of Pharmacology and Experimental Therapeutics. 289(3). 1229–1236. 36 indexed citations
4.
Cook, C. D., F.I. Carroll, & Patrick M. Beardsley. (1998). Separation of the locomotor stimulant and discriminative stimulus effects of cocaine by its C-2 phenyl ester analog, RTI-15. Drug and Alcohol Dependence. 50(2). 123–128. 4 indexed citations
5.
Boja, J.W., F.I. Carroll, Roxanne A. Vaughan, Theresa Kopajtic, & M J Kuhar. (1998). Multiple binding sites for [125I]RTI-121 and other cocaine analogs in rat frontal cerebral cortex. Synapse. 30(1). 9–17. 11 indexed citations
6.
Burgess, Jason P., et al.. (1997). Synthesis and Transporter Binding Properties of 2,3-Diphenyltropane Stereoisomers. Comparison to 3β-Phenyltropane-2β-carboxylic Acid Esters. Journal of Medicinal Chemistry. 40(8). 1247–1251. 9 indexed citations
7.
Kotian, Pravin L., S. Wayne Mascarella, Philip Abraham, et al.. (1996). Synthesis, Ligand Binding, and Quantitative Structure−Activity Relationship Study of 3β-(4‘-Substituted phenyl)-2β-heterocyclic Tropanes:  Evidence for an Electrostatic Interaction at the 2β-Position. Journal of Medicinal Chemistry. 39(14). 2753–2763. 58 indexed citations
8.
Kotian, Pravin L., Anita H. Lewin, S. Wayne Mascarella, et al.. (1995). Synthesis and Ligand Binding Study of 3.beta.-(4'-Substituted phenyl)-2.beta.-(heterocyclic)tropanes. Journal of Medicinal Chemistry. 38(18). 3451–3453. 20 indexed citations
9.
Little, Karley Y., F.I. Carroll, & Barbara Cassin. (1995). Characterization and localization of [125I]RTI-121 binding sites in human striatum and medial temporal lobe.. Journal of Pharmacology and Experimental Therapeutics. 274(3). 1473–1483. 36 indexed citations
10.
Lewin, Anita H., et al.. (1994). Evaluation of Retinoids as Therapeutic Agents in Dermatology. Pharmaceutical Research. 11(2). 192–200. 15 indexed citations
11.
Scheffel, Ursula, R. F. Dannals, Makiko Suehiro, et al.. (1994). Development of PET/SPECT Ligands for the Serotonin Transporter. PsycEXTRA Dataset. 138. 111–30. 18 indexed citations
12.
Lewin, Anita H., et al.. (1994). The Requirement for a Retinoic Acid Lactone of 11-cis, 13-cis-Stereochemistry for Topical Dermatologic Activity. Pharmaceutical Research. 11(7). 1065–1067. 1 indexed citations
13.
Dersch, Christina M., John S. Partilla, F.I. Carroll, et al.. (1994). [125]RTI-55, a high affinity cocaine analog, labels two binding sites in human caudate membranes possibly related to the 5-HT transporter. Biological Psychiatry. 35(9). 644–644. 1 indexed citations
14.
Abraham, Philip, J. Bruce Pitner, Anita H. Lewin, et al.. (1992). N-Modified analogs of cocaine: synthesis and inhibition of binding to the cocaine receptor. Journal of Medicinal Chemistry. 35(1). 141–144. 61 indexed citations
15.
Abraham, Philip, et al.. (1990). A concise synthesis of (±)-, (+)-, and (–)-6-methyl-6-azabicyclo[3.2.l]octan-3α-ol. Journal of the Chemical Society Chemical Communications. 984–985. 10 indexed citations
16.
Carroll, F.I., Philip Abraham, R. C. Griffith, et al.. (1987). 6-Methyl-6-azabicyclo[3.2.1]octan-3.alpha.-ol 2,2-diphenylpropionate (azaprophen), a highly potent antimuscarinic agent. Journal of Medicinal Chemistry. 30(5). 805–809. 42 indexed citations
17.
Carroll, F.I., et al.. (1981). Synthesis and pharmacological activity of thiohexital enantiomers. Journal of Medicinal Chemistry. 24(10). 1241–1244. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026